These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Measurement of regional neuronal removal of norepinephrine in man. Goldstein DS, Zimlichman R, Stull R, Folio J, Levinson PD, Keiser HR, Kopin IJ. J Clin Invest; 1985 Jul; 76(1):15-21. PubMed ID: 4019774 [Abstract] [Full Text] [Related]
3. Decreased sympathetic neuronal uptake in idiopathic orthostatic hypotension. Polinsky RJ, Goldstein DS, Brown RT, Keiser HR, Kopin IJ. Ann Neurol; 1985 Jul; 18(1):48-53. PubMed ID: 4037750 [Abstract] [Full Text] [Related]
4. Correction of cardiovascular hypersensitivity to norepinephrine by potassium supplementation in normotensive members of hypertensive families and patients with essential hypertension. Bianchetti MG, Beretta-Piccoli C, Weidmann P, Ferrier C, Link L, Gerber A. J Hypertens Suppl; 1984 Dec; 2(3):S445-8. PubMed ID: 6599696 [Abstract] [Full Text] [Related]
8. Effect of sympathetic and plasma renin activity on hemodialysis hypertension. Grekas D, Kalevrosoglou I, Karamouzis M, Geropoulou E, Kabouris H, Tourkantonis A. Clin Nephrol; 2001 Feb; 55(2):115-20. PubMed ID: 11269674 [Abstract] [Full Text] [Related]
9. The role of the adrenergic system in hypertension after renal transplantation. Smith RS, Reid JL, Warren DJ. Proc Eur Dial Transplant Assoc; 1981 Feb; 18():608-14. PubMed ID: 7036175 [Abstract] [Full Text] [Related]
10. Noradrenaline and isoproterenol kinetics in diabetic patients with and without autonomic neuropathy. Dejgaard A, Hilsted J, Christensen NJ. Diabetologia; 1986 Nov; 29(11):773-7. PubMed ID: 3028892 [Abstract] [Full Text] [Related]
11. Increased arterial catecholamine concentrations in 50-year-old men with essential hypertension. Kjeldsen SE, Eide I, Aakesson I, Leren P. Scand J Clin Lab Invest; 1983 Jun; 43(4):343-9. PubMed ID: 6635541 [Abstract] [Full Text] [Related]
12. [Effects of adrenergic stimulation on transmembrane transport of Na+ in patients with essential hypertension]. Saitta A, Saitta MN, Messina A, Bonaiuto M, Cinquegrani M, Squadrito G, Castaldo M, Sardo A, Imbalzano E, Squadrito F. Minerva Med; 1997 Jun; 88(7-8):275-82. PubMed ID: 9304069 [Abstract] [Full Text] [Related]
16. Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity-related hypertension. Golan E, Tal B, Dror Y, Korzets Z, Vered Y, Weiss E, Bernheim J. Isr Med Assoc J; 2002 Jun; 4(6):426-30. PubMed ID: 12073415 [Abstract] [Full Text] [Related]
17. Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients. Esler M, Jackman G, Bobik A, Leonard P, Kelleher D, Skews H, Jennings G, Korner P. Hypertension; 1981 Jun; 3(2):149-56. PubMed ID: 7216371 [Abstract] [Full Text] [Related]
18. Plasma norepinephrine in humans: limitations in assessment of whole body norepinephrine kinetics and plasma clearance. Henriksen JH, Christensen NJ. Am J Physiol; 1989 Nov; 257(5 Pt 1):E743-50. PubMed ID: 2596601 [Abstract] [Full Text] [Related]
19. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients. de Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB, Nadeau R, Larochelle P. J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123 [Abstract] [Full Text] [Related]